Document Detail


Serum S100B levels in X-linked adrenoleukodystrophy and Gaucher disease.
MedLine Citation:
PMID:  17705023     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
S100B, a small acidic protein, is a member of a multigenic family of calcium-modulated proteins. It is mainly produced by astrocytes and the secreted protein, depending on its concentration, can exert either trophic or toxic effects. In humans increased S100B levels have been detected in brain trauma and ischaemia, and neurodegenerative, neurometabolic, inflammatory and psychiatric disease. Serum S100B concentrations have been used as markers of brain disease. In the present study S100B serum levels were determined in patients with the neuroinflammatory disease X-linked adrenoleukodystrophy (X-ALD) and in patients with both the acute neuronopathic (type II) and the non-neuronopathic (type I) types of Gaucher disease (GD). Sixteen X-ALD patients (10 with the childhood, 4 with the adult cerebral forms, 2 asymptomatic) and 22 Gaucher disease patients (19 type I, 3 type II) were studied. No statistically significant differences were observed between the X-ALD (median 0.13 microg/L, p=0.191) or Gaucher type I patients (median 0.07 microg/L, p=0.095) and controls of similar age (median 0.10 microg/L, n=22). Serum S100B levels of type II Gaucher disease patients were also within the normal for their age range (patients 0.2, 0.22, 0.65; control median 0.81 microg/L, n=44). Lack of clinical symptoms and/or MRI findings in X-ALD patients was not associated with lower S100B values. Our results indicate that serum S100B levels cannot serve as peripheral marker in the evaluation of brain disease in X-ALD and GD.
Authors:
H Michelakakis; C Kariyannis; M Moraitou; E Dimitriou; J Sarafidou; I Papassotiriou
Related Documents :
1063413 - Cancer-associated isoenzyme of serum galactosyltransferase.
2484753 - Serum zinc and copper in patients with atherosclerosis and thromboangiitis obliterans.
9785203 - Neurologic complications after coronary artery bypass grafting.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2007-08-20
Journal Detail:
Title:  Journal of inherited metabolic disease     Volume:  30     ISSN:  1573-2665     ISO Abbreviation:  J. Inherit. Metab. Dis.     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-10-10     Completed Date:  2007-10-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7910918     Medline TA:  J Inherit Metab Dis     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  822     Citation Subset:  IM    
Affiliation:
Enzymology and Cellular Function Department, Institute of Child Health, Aghia Sophia Children's Hospital, Athens, Greece. inchildh@otenet.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenoleukodystrophy / blood*
Biological Markers / blood
Gaucher Disease / blood*
Humans
Nerve Growth Factors / blood*
S100 Proteins / blood*
Severity of Illness Index
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Nerve Growth Factors; 0/S-100 calcium-binding protein beta subunit; 0/S100 Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of weight on the content of trace metals in tissues of Mytilus galloprovincialis (Lamarck,...
Next Document:  Three successful pregnancies through dietary management of fructose-1,6-bisphosphatase deficiency.